What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?

Liam Hayman, Wajeeh Raza Chaudhry, Victor V. Revin, Nikolai Zhelev, Jean-Christophe Bourdon

    Research output: Contribution to journalArticle

    Abstract

    Introduction: For decades, p53 was researched as a single protein with alterations described as mutants. The discovery of 12 human p53 isoforms expressed from 9 transcripts changed this perception, eloquently explaining the numerous roles p53 plays, including apoptosis, senescence and regeneration. 

    Area covered: Here, we summarise the p53 isoforms and their relevance to cancer to establish an understanding and theorise on potential applications of the isoforms in clinical practice. 

    Expert commentary: Pertaining to the different expression of isoforms in different tumours, it is concluded that the clinical use of isoforms as prognostic and predictive biomarkers will be different depending on the cell type, the tissue origin of the tumours, the position of the TP53 mutation and the driver-oncogene.

    Original languageEnglish
    Pages (from-to)149-159
    Number of pages11
    JournalExpert Review of Molecular Diagnostics
    Volume19
    Issue number2
    Early online date7 Jan 2019
    DOIs
    Publication statusPublished - 2019

    Fingerprint

    Protein Isoforms
    Biomarkers
    Neoplasms
    Oncogenes
    Regeneration
    Apoptosis
    Mutation
    Proteins

    Cite this

    Hayman, Liam ; Chaudhry, Wajeeh Raza ; Revin, Victor V. ; Zhelev, Nikolai ; Bourdon, Jean-Christophe. / What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?. In: Expert Review of Molecular Diagnostics. 2019 ; Vol. 19, No. 2. pp. 149-159.
    @article{1754d607877d4abbbac8cc3b4e807d30,
    title = "What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?",
    abstract = "Introduction: For decades, p53 was researched as a single protein with alterations described as mutants. The discovery of 12 human p53 isoforms expressed from 9 transcripts changed this perception, eloquently explaining the numerous roles p53 plays, including apoptosis, senescence and regeneration. Area covered: Here, we summarise the p53 isoforms and their relevance to cancer to establish an understanding and theorise on potential applications of the isoforms in clinical practice. Expert commentary: Pertaining to the different expression of isoforms in different tumours, it is concluded that the clinical use of isoforms as prognostic and predictive biomarkers will be different depending on the cell type, the tissue origin of the tumours, the position of the TP53 mutation and the driver-oncogene.",
    author = "Liam Hayman and Chaudhry, {Wajeeh Raza} and Revin, {Victor V.} and Nikolai Zhelev and Jean-Christophe Bourdon",
    year = "2019",
    doi = "10.1080/14737159.2019.1563484",
    language = "English",
    volume = "19",
    pages = "149--159",
    journal = "Expert Review of Molecular Diagnostics",
    issn = "1473-7159",
    publisher = "Expert Reviews Ltd.",
    number = "2",

    }

    What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer? / Hayman, Liam; Chaudhry, Wajeeh Raza; Revin, Victor V.; Zhelev, Nikolai; Bourdon, Jean-Christophe.

    In: Expert Review of Molecular Diagnostics, Vol. 19, No. 2, 2019, p. 149-159.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?

    AU - Hayman, Liam

    AU - Chaudhry, Wajeeh Raza

    AU - Revin, Victor V.

    AU - Zhelev, Nikolai

    AU - Bourdon, Jean-Christophe

    PY - 2019

    Y1 - 2019

    N2 - Introduction: For decades, p53 was researched as a single protein with alterations described as mutants. The discovery of 12 human p53 isoforms expressed from 9 transcripts changed this perception, eloquently explaining the numerous roles p53 plays, including apoptosis, senescence and regeneration. Area covered: Here, we summarise the p53 isoforms and their relevance to cancer to establish an understanding and theorise on potential applications of the isoforms in clinical practice. Expert commentary: Pertaining to the different expression of isoforms in different tumours, it is concluded that the clinical use of isoforms as prognostic and predictive biomarkers will be different depending on the cell type, the tissue origin of the tumours, the position of the TP53 mutation and the driver-oncogene.

    AB - Introduction: For decades, p53 was researched as a single protein with alterations described as mutants. The discovery of 12 human p53 isoforms expressed from 9 transcripts changed this perception, eloquently explaining the numerous roles p53 plays, including apoptosis, senescence and regeneration. Area covered: Here, we summarise the p53 isoforms and their relevance to cancer to establish an understanding and theorise on potential applications of the isoforms in clinical practice. Expert commentary: Pertaining to the different expression of isoforms in different tumours, it is concluded that the clinical use of isoforms as prognostic and predictive biomarkers will be different depending on the cell type, the tissue origin of the tumours, the position of the TP53 mutation and the driver-oncogene.

    U2 - 10.1080/14737159.2019.1563484

    DO - 10.1080/14737159.2019.1563484

    M3 - Article

    VL - 19

    SP - 149

    EP - 159

    JO - Expert Review of Molecular Diagnostics

    JF - Expert Review of Molecular Diagnostics

    SN - 1473-7159

    IS - 2

    ER -